XML 15 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Dow Consolidated Statements of Income Statement - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Net sales $ 13,885 $ 8,354 $ 25,767 $ 18,124
Cost of sales 10,740 7,610 20,802 15,840
Research and development expenses 228 182 422 361
Selling, general and administrative expenses 440 357 806 691
Amortization of intangibles 100 100 201 200
Restructuring and asset related charges - net 22 6 22 102
Integration and separation costs 0 46 0 111
Equity in earnings (losses) of nonconsolidated affiliates 278 (95) 502 (184)
Sundry income (expense) - net (3) 53 125 (28)
Interest income 13 6 21 21
Interest expense and amortization of debt discount 187 200 383 415
Income (loss) before income taxes 2,456 (183) 3,779 213
Provision for income taxes 524 34 841 172
Net income (loss) 1,932 (217) 2,938 41
Net income attributable to noncontrolling interests 31 8 46 27
Net income (loss) available for The Dow Chemical Company common stockholder $ 1,901 $ (225) $ 2,892 $ 14
Earnings (loss) per common share - basic $ 2.53 $ (0.31) $ 3.86 $ 0.01
Earnings (loss) per common share - diluted $ 2.51 $ (0.31) $ 3.83 $ 0.01
Weighted-average common shares outstanding - basic 747.0 739.3 745.9 739.7
Weighted-average common shares outstanding - diluted 752.9 739.3 751.4 741.0